Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia

NCT01025388 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01025388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01025388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
May 31, 2010
Enrollment
4,053 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia